Skip to content
Open access

Targeted proteomics of postmortem human brain reveals neurobiologic heterogeneity in Alzheimer’s disease using NULISA technology

Jul 2026 · bioRxiv · 0 citations · 32 references
Biology Medicine
Read PDF